These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28929546)

  • 41. Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study.
    Holmbom M; Forsberg J; Fredrikson M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A
    Scand J Urol; 2023 Aug; 58():32-37. PubMed ID: 37553957
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A prospective randomized comparative study of targeted versus empirical prophylactic antibiotics in the prevention of infective complications following transrectal ultrasound-guided prostate biopsy.
    Doherty AF; Ikuerowo SO; Jeje EA; Ibrahim NA; Ojongbede OL; Mutiu WB; Omisanjo OA; Abolarinwa AA
    Ann Afr Med; 2019; 18(3):132-137. PubMed ID: 31417013
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Routine Ertapenem Prophylaxis for Transrectal Ultrasound Guided Prostate Biopsy does Not Select for Carbapenem Resistant Organisms: A Prospective Cohort Study.
    Bloomfield MG; Page MJ; McLachlan AG; Studd RC; Blackmore TK
    J Urol; 2017 Aug; 198(2):362-368. PubMed ID: 28288838
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Povidone-iodine rectal cleansing and targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy are associated with reduced incidence of postoperative infectious complications.
    Ryu JW; Jung SI; Ahn JH; Hwang EC; Yu HS; Kang TW; Kwon DD; Park K; Kim JW
    Int Urol Nephrol; 2016 Nov; 48(11):1763-1770. PubMed ID: 27495324
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis.
    Shigehara K; Miyagi T; Nakashima T; Shimamura M
    J Infect Chemother; 2008 Feb; 14(1):40-3. PubMed ID: 18297448
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Role of Ciprofloxacin Resistance and Extended-spectrum beta-lactamase (ESBL) Positivity in Infective Complications Following Prostate Biopsy.
    Korkmaz N; Gurbuz Y; Sandikci F; Kul G; Tutuncu EE; Sencan I
    Urol J; 2020 Mar; 17(2):192-197. PubMed ID: 31364100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome.
    Ortega M; Marco F; Soriano A; Almela M; Martínez JA; Muñoz A; Mensa J
    J Antimicrob Chemother; 2009 Mar; 63(3):568-74. PubMed ID: 19126669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
    Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
    Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rectal Culture-Guided Targeted Antimicrobial Prophylaxis Reduces the Incidence of Post-Operative Infectious Complications in Men at High Risk for Infections Submitted to Transrectal Ultrasound Prostate Biopsy - Results of a Cross-Sectional Study.
    Boeri L; Fontana M; Gallioli A; Zanetti SP; Catellani M; Longo F; Mangiarotti B; Montanari E
    PLoS One; 2017; 12(1):e0170319. PubMed ID: 28122053
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative Effectiveness of Targeted vs Empirical Antibiotic Prophylaxis to Prevent Sepsis from Transrectal Prostate Biopsy: A Retrospective Analysis.
    Liss MA; Kim W; Moskowitz D; Szabo RJ
    J Urol; 2015 Aug; 194(2):397-402. PubMed ID: 25846415
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluoroquinolone-based antimicrobial prophylaxis in patients undergoing transrectal ultrasound-guided prostate biopsy.
    Sieczkowski M; Gibas A; Bronk M; Matuszewski M
    Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1815-21. PubMed ID: 26048634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of ST131 among fluoroquinolone-resistant Escherichia coli obtained from rectal swabs before transrectal prostate biopsy.
    Liss MA; Peterson EM; Johnston B; Osann K; Johnson JR
    Urology; 2013 Mar; 81(3):548-55. PubMed ID: 23333000
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cefoxitin-based antibiotic therapy for extended-spectrum β-lactamase-producing Enterobacteriaceae prostatitis: a prospective pilot study.
    Demonchy E; Courjon J; Ughetto E; Durand M; Risso K; Garraffo R; Roger PM
    Int J Antimicrob Agents; 2018 Jun; 51(6):836-841. PubMed ID: 29378342
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeted Antimicrobial Prophylaxis Does Not Always Prevent Sepsis after Transrectal Prostate Biopsy.
    Jiang P; Liss MA; Szabo RJ
    J Urol; 2018 Aug; 200(2):361-368. PubMed ID: 29574110
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor.
    Mosharafa AA; Torky MH; El Said WM; Meshref A
    Urology; 2011 Sep; 78(3):511-4. PubMed ID: 21782225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rectal colonization with New Delhi metallo-β-lactamase-1-producing Escherichia coli prior to transrectal ultrasound (TRUS)-guided prostate biopsy.
    Williamson DA; Freeman JT; Roberts SA; Heffernan H; Dyet K; Paterson DL; Rogers BA; Sidjabat HE; Masters J
    J Antimicrob Chemother; 2013 Dec; 68(12):2957-9. PubMed ID: 23825384
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of antibiotic susceptibility of Escherichia coli between community-acquired and post-prostate biopsy acute bacterial prostatitis.
    Park MG; Cho MC; Cho SY; Lee JW
    Arch Esp Urol; 2019 Dec; 72(10):1018-1025. PubMed ID: 31823850
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Value of Rectal Cultures in Treatment of Sepsis Following Post-Transrectal Ultrasound-Guided Prostate Biopsy.
    Gottesman T; Yossepowich O; Harari-Schwartz O; Tsivian A; Idler J; Dan M
    Urol Int; 2015; 95(2):177-82. PubMed ID: 25871322
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment.
    Zaytoun OM; Vargo EH; Rajan R; Berglund R; Gordon S; Jones JS
    Urology; 2011 May; 77(5):1035-41. PubMed ID: 21420152
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. isolates in Mongolia.
    Kao CY; Udval U; Huang YT; Wu HM; Huang AH; Bolormaa E; Yan JJ; Urangoo Z; Batbaatar G; Khosbayar T; Wu JJ
    J Microbiol Immunol Infect; 2016 Oct; 49(5):692-700. PubMed ID: 26194952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.